NYSE:PTHS

Channel Therapeutics Stock Forecast

etoro logo Buy PTHS
*Your capital is at risk
$27.26
+0.440 (+1.64%)
At Close: Jul 20, 2026
AI Analysis AI Analysis of PTHS AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PTHS to Watchlist?
Some Reasons Why To Add PTHS:
  • Highly efficient cash conversion (101% FCF/OCF ratio)
  • Trading above its 200-day moving average
  • High gross margin of 47.0%
PDF

Channel Therapeutics Corporation stock upgraded from Sell Candidate to Buy Candidate after Monday trading session
(Updated on Jul 20, 2026)

Buy candidate since Jul 20, 2026

The Channel Therapeutics Corporation stock price gained 1.64% on the last trading day (Monday, 20th Jul 2026), rising from $26.82 to $27.26. During the last trading day the stock fluctuated 8.24% from a day low at $26.77 to a day high of $28.98. The price has fallen in 6 of the last 10 days but is still up by 9.57% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 166 thousand more shares were traded than the day before. In total, 176 thousand shares were bought and sold for approximately $4.80 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.77% during the next 3 months and, with a 90% probability hold a price between $27.73 and $33.64 at the end of this 3-month period.

PTHS Signals & Forecast

The Channel Therapeutics Corporation stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $26.60 and $27.12. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, July 07, 2026, and so far it has risen 10.81%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Channel Therapeutics Corporation stock

Channel Therapeutics Corporation finds support from accumulated volume at $27.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.21 between high and low, or 8.24%. For the last week, the stock has had daily average volatility of 7.94%.

Our recommended stop-loss: $26.16 (-4.02%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 9 days ago.)

Trading Expectations (PTHS) For The Upcoming Trading Day Of Tuesday 21st

For the upcoming trading day on Tuesday, 21st we expect Channel Therapeutics Corporation to open at $27.67, and during the day (based on 14 day Average True Range), to move between $26.38 and $28.14, which gives a possible trading interval of +/-$1.76 (+/-6.69%) up or down from last closing price. If Channel Therapeutics Corporation takes out the full calculated possible swing range there will be an estimated 6.69% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $27.00 (0.95%) than the resistance at $27.69 (1.58%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Channel Therapeutics Corporation stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Channel Therapeutics Corporation stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 3.157 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 21, 2026 - $27.67 ( 1.50%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PTHS Performance

Trading levels for PTHS

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 29.87 9.59%
R2 29.03 6.50%
R1 28.51 4.59%
Price 27.26
S1 26.83 -1.59%
S2 26.31 -3.50%
S3 25.46 -6.59%

Accumulated Volume Support & Resistance Levels

Level Price
R3 28.26 3.67%
R2 28.00 2.71%
R1 27.69 1.58%
Price 27.26
S1 27.00 -0.95%
S2 26.87 -1.43%
S3 26.50 -2.79%

FAQ

What is the symbol for Channel Therapeutics Corporation Stock and on which exchange is it traded?
The symbol for Channel Therapeutics Corporation is PTHS and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Channel Therapeutics Corporation Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Channel Therapeutics Corporation stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

How to buy Channel Therapeutics Corporation Stock?
Channel Therapeutics Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Channel Therapeutics Corporation Stock.

What's the current price of Channel Therapeutics Corporation Stock?
As of the end of day on the Jul 20, 2026, the price of an Channel Therapeutics Corporation (PTHS) share was $27.26.

What is the 52-week high and low for Channel Therapeutics Corporation Stock?
The 52-week high for Channel Therapeutics Corporation Stock is $37.50 and the 52-week low is $16.50.

What is the market capitalization of Channel Therapeutics Corporation Stock?
As of the Jul 20, 2026, the market capitalization of Channel Therapeutics Corporation is 17.678M.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
3.35% Jul 13
JLL
$299.78
8.73% Jun 24
NMRK
$15.02
3.26% Jun 24
NESR
$25.07
8.62% Jun 23
CAG
$13.43
9.20% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE